Annovis Bio Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 23, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	56	67	174	103	125	42
Market Cap Growth	-5.01%	-61.39%	69.23%	-18.07%	194.78%	-
Enterprise Value	43	55	168	73	83	35
Last Close Price	2.02	4.96	18.00	12.14	15.80	5.30
PB Ratio	4.98	7.46	-24.76	3.87	3.20	6.89
P/TBV Ratio	4.98	7.46	-	3.87	3.20	6.89
Net Debt / Equity Ratio	-1.16	-1.13	0.74	-1.00	-1.03	-1.07
Quick Ratio	4.09	2.72	1.35	3.69	30.33	13.96
Current Ratio	4.60	3.59	2.39	4.68	30.54	14.04
Return on Equity (ROE)	-246.14%	-3159.09%	-546.40%	-69.57%	-55.68%	-180.82%
Return on Assets (ROA)	-105.88%	-138.26%	-121.77%	-38.88%	-33.58%	-89.86%
Return on Capital Employed (ROCE)	-198.60%	-265.80%	-759.60%	-90.10%	-32.70%	-88.10%
Earnings Yield	-38.02%	-35.43%	-29.29%	-23.10%	-10.17%	-10.51%
Buyback Yield / Dilution	-61.36%	-35.60%	-10.55%	-7.03%	-20.88%	-2132.36%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.